top of page

Newborn Genomic Sequencing Programs

Baby Holding Finger
For Ministries of Health and National Program Leaders

 

We help countries design, pilot and scale
newborn genomic screening programmes.

​

From initial feasibility to national rollout, using global evidence adapted to your local constraints.

​

Our core offer: End-to-end implementation support across the full programme lifecycle, with evidence-based recommendations tailored to your regulatory, fiscal, and infrastructural context.

What 10 programs and 520 papers have taught us
about newborn genomic sequencing implementation

Before we tell you how we work, or advise you how to work, here's what we've learned from ten  active newborn sequencing programs, including the UK's Generation Study, and from 520 publications. 

Some countries only discover too late, the errors which could have been avoided, and the real-world experience and learning, which is crucial for the implementation of successful genomics sequencing programs.

These patterns appear across high-income, middle-income, and resource-limited settings.

At GENEQ Global, we help our clients to avoid the pitfalls, and benefit from our experience, through planning, piloting, and scaling of newborn genomic sequencing studies and programs.

Genomic Sequencing Services Mapped.png

1

Co-production

We work alongside your technical committees, ethics boards, and finance ministries - not just hand over documents. Your national experts lead; we support with global evidence.

2

Adapted to your context

No UK-style blueprints forced onto different systems. We start with your regulatory, fiscal, and infrastructural reality and build recommendations that are actually feasible.

3

Options, not prescriptions

When national stakeholders wish to delve deeper into our analysis, we present transparent options with pros and cons.

We respect national sovereignty and community norms.

scaling newborn sequencing programmes.png

How Decisions Differ Based On Your Starting Point

We don't sell a single template. We use data and evidence, across multiple contexts, to appropriately advise on the design of your program:

International Genomic Sequencing Contexts.png

How Our Intelligence Translates to Your Decisions

Example: A Ministry of Health asks: "Should we start with a 50-condition panel or go straight to whole genome sequencing?"​​

Within three weeks, we would:

  • Analyse your existing laboratory capacity and workforce

  • Map population-prevalent conditions in your country

  • Cost both approaches against your budget constraints

  • Benchmark against 3 comparable countries

And co-develop with your team:

  • Option A: Targeted panel with upgrade pathway

  • Option B: WGS pilot in selected sites

  • Option C: Hybrid approach (panel now, WGS in 5 years)​

  • Decision matrix with your governance criteria

bottom of page